Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
09/2003
09/10/2003EP1342781A1 Recombinase fusion protein with enhanced cellular uptake
09/10/2003EP1342085A2 Non-apoptotic forms of cell death and methods of modulation
09/10/2003EP1341929A2 Fen endonucleases
09/10/2003EP1341926A2 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production
09/10/2003EP1341921A2 Hydrolases
09/10/2003EP1341920A2 Human elongase genes and uses thereof
09/10/2003EP1341919A2 Novel human kinases and uses thereof
09/10/2003EP1341918A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/10/2003EP1341917A2 26199, 33530, 33949, 47148, 50226, and 58764, human transferase family members and uses therefor
09/10/2003EP1341916A2 Abscisic acid 8'- and 7'- hydroxylase genes and related sequences from plants
09/10/2003EP1341908A2 Targeted enzyme prodrug therapy
09/10/2003EP1341907A2 Target enzymes
09/10/2003EP1341906A2 Novel human kinase and polynucleotides encoding the same
09/10/2003EP1341905A2 Tec kinase assay
09/10/2003EP1341904A1 Zipper protein kinase and uses thereof
09/10/2003EP1341903A2 Plant derived hydroxy phenyl pyruvate dioxygneases (hppd) resistant against triketone herbicides and transgenic plants containing these dioxygenases
09/10/2003EP1341808A2 Synthetic nucleic acid molecule compositions and methods of preparation
09/10/2003EP1341804A2 Novel nucleic acids and polypeptides
09/10/2003EP1341778A1 Klainetin and derivatives thereof, method for their production and the use of the same
09/10/2003EP1253937B1 Use of thrombin derived peptides for the treatment of cardiovascular disorders
09/10/2003EP1054689B1 Strategically modified hepatitis b core proteins and their derivatives
09/10/2003CN1441847A Recobinant plasmid PSP1, microorganisms transformed therewith, and method for producing alkaline protease VAPK
09/10/2003CN1441846A Recombinant plasmid PDSBCM, microorganisms transformed therewith, and method for producing alkaline protease VAPK
09/10/2003CN1441845A Method of detecting and quantifying human P450 molecular species and probe and kit for this method
09/10/2003CN1441806A Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties
09/10/2003CN1441784A Thrombin inhibitors comprising aminoisoquinoline group
09/10/2003CN1441056A Combined mutant of histotypic plasminogen activator
09/10/2003CN1440751A Matrix metal proteinase and tumor necrosis inhibitor
09/09/2003US6617497 Transformed plant comprising a nucleic acid encoding a protein that exhibits enzymatic activity; can use to alter pathogen resistance and plant growth properties
09/09/2003US6617495 Nucleic acid molecules from plants coding enzymes which participate in the starch synthesis
09/09/2003US6617493 Nucleotide sequence encoding soybean vestitone reductase
09/09/2003US6617442 Human Rnase H1 and oligonucleotide compositions thereof
09/09/2003US6617435 Infiltrating a plant tissue with a buffer solution; subjecting plant tissue and buffer solution to a substantially vacuum environment; removing tissue from the buffer solution; centrifuging the tissue to remove interstitial fluid;
09/09/2003US6617434 Isolated antibody which binds selectively to tsp50 (testes-specific protease) protein of given amino acid sequence; use in diagnosis and treatment of breast cancer
09/09/2003US6617426 Peptide analogs of given formula; useful in treating neurodegenerative, autoimmune, cognitive disorders, stroke and traumatic injury
09/09/2003US6617171 Detecting immunological defects in mammal; obtain sample tissue from mammal, detect proteasome activity, reduction in proteasome activty indicates immunological defect
09/09/2003US6617147 Nucleotide sequences coding polypeptides for use in human therapeutics and diagnostics
09/09/2003US6617145 Enzymatic protein for use in treatment of thrombosis
09/09/2003US6617144 Motor proteins and methods for their use
09/09/2003US6617143 Polypeptides having glucanotransferase activity and nucleic acids encoding same
09/09/2003US6617140 Process for producing trans-4-hydroxy-L-proline
09/09/2003US6617139 Isolated protein of given sequence; stereoselectively hydrolyzes alpha -amino acid amides and alpha -hydroxy acid amides
09/09/2003US6617136 Comprises polymerase or a ligase and near-infrared diiminium dye or cyanine dye; amplification
09/09/2003US6617127 Synthesis and recovery of aspartame involving enzymatic deformylation step
09/09/2003US6617125 Compositions for enhanced catalyzed reporter deposition
09/09/2003US6617117 MAP kinases: polypeptides, polynucleotides and uses thereof
09/09/2003US6617110 Cultured cell comprising a nucleic acid sequence, encoding the protein, that hybridizes to a polynucleotide of given sequence; use to determine if drug is cytotoxic; can use as anticarcinogenic agent
09/09/2003US6617102 Screening for a bioactive agent capable of interfering with the binding of a protein; use in diagnosis and treatment of cancer
09/05/2003CA2374527A1 Gene of enzyme activity to generate lachrymatory factor
09/04/2003WO2003089641A2 Dual condensation/epimerization domain in non-ribosomal peptide synthetase systems
09/04/2003WO2003073238A2 Computational method for designing enzymes for incorporation of amino acid analogs into proteins
09/04/2003WO2003073068A2 Population based assessments and means to rank the relative immunogenicity of proteins
09/04/2003WO2003073067A2 Rna detection enzymes
09/04/2003WO2003072808A1 Assay for activity of the actriib kinase
09/04/2003WO2003072800A2 Haemophilus adherence and penetration proteins
09/04/2003WO2003072792A2 A method of selectively producing male or female sterile plants
09/04/2003WO2003072791A2 Transgenic fodder plants with an increased leaf starch content
09/04/2003WO2003072790A2 Production of dadzein in transgenic plants
09/04/2003WO2003072789A2 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
09/04/2003WO2003072787A2 Method for detection of leptin receptor ligands
09/04/2003WO2003072786A1 Process for producing l-threonine with the use of bacterium beloniging to the genus escherichia
09/04/2003WO2003072785A2 Fermentation process
09/04/2003WO2003072784A1 Delta 6-desaturases from primulaceae, expressing plants and pufa-containing oils
09/04/2003WO2003072776A1 Gene encoding novel enzyme catalyzing glycosyl transfer reaction and process for producing the enzyme
09/04/2003WO2003072773A1 Fused protein having glucuronyl transferase activity
09/04/2003WO2003072770A1 Novel dehydrogenase and gene encoding the same
09/04/2003WO2003072769A1 Cytochrome p450 protein
09/04/2003WO2003072768A2 Modified human manganese superoxide dismutase and uses thereof
09/04/2003WO2003072767A2 Regulation of human lipase
09/04/2003WO2003072763A1 Increasing plant seed production
09/04/2003WO2003072760A2 Method for cloning and expression of bsawi restriction endonuclease and bsawi methylase in e. coli
09/04/2003WO2003072751A2 Expression system for human brain-specific voltage-gated sodium channel, type 1
09/04/2003WO2003072746A2 Subtilisin carlsberg proteins with reduced immunogenicity
09/04/2003WO2003072743A2 Method for the recombination of genetic elements
09/04/2003WO2003072742A2 Novel glucose 6-oxidases
09/04/2003WO2003072741A2 Therapeutic regulation of deoxyribonuclease-1-like-3 activity
09/04/2003WO2003072733A2 Modified bace
09/04/2003WO2003072729A2 Enzymes
09/04/2003WO2003072726A2 Nad phosphite oxidoreductase a novel catalyst from bacteria for regeneration of nad(p)h
09/04/2003WO2003072724A2 Human analogs of murine deubiquitinating protease genes
09/04/2003WO2003072717A2 Grain-based enzyme-releasing matrix and method of preparation
09/04/2003WO2003072702A2 Merhod for cloning and expression of mspa1i restriction endonuclease and mspa1i methylase in e. coli
09/04/2003WO2003072698A2 Surface proteins of leptospira
09/04/2003WO2003072609A1 Tick chitinase
09/04/2003WO2003072114A1 Vascular therapeutics
09/04/2003WO2003072018A2 Ricin vaccine and methods of making and using thereof
09/04/2003WO2003071861A2 Vanillin biosynthetic pathway enzyme from vanilla planifolia
09/04/2003WO2003064451A3 MODULATION OF TYPE IIβ PHOSPHOINOSITIDE PHOSPHATE KINASE
09/04/2003WO2003046003A3 Plasma protease c1 biopolymer markers predictive of alzheimers disease
09/04/2003WO2003040379A3 Modulating urea degradation in wine yeast
09/04/2003WO2003040302A3 Restriction-modification endonuclease sub-unit protein
09/04/2003WO2003027297A9 PROCESS FOR PRODUCING α2,3/α2,8-SIALYLTRANSFERASE AND SIALIC ACID-CONTAINING COMPLEX SUGAR
09/04/2003WO2003027225A3 Regulation of human steroid 5-alpha reductase
09/04/2003WO2003025162A3 Regulation of human prolyl 4-hydroxylase alpha subunit precursor
09/04/2003WO2003014366A3 Rna amplification system using plant components in animal cells
09/04/2003WO2003009808A3 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
09/04/2003WO2003008616A3 PROCESS FOR THE PREPARATION OF L-AMINO ACIDS USING STRAINS OF THE ENTEROBACTERIACEAE FAMILY WHICH CONTAIN AN ATTENUATED aceK GENE
09/04/2003WO2003000882A3 Transgenic models for glucose homeostasis comrpising human gsk-3
09/04/2003WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
09/04/2003WO2002098918A3 Novel targets for a therapeutic intervention in ebv related diseases
1 ... 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 ... 1416